Results overview: Found 1 records in 0.01 seconds.
Research literature, 1 records found
Research literature 1 records found  
1.
147 p, 2.3 MB A Study of multi-parametric MRI as a prognostic and response biomarker in patients with castration resistant prostate carcinoma and bone metastases / Perez Lopez, Raquel ; de Bono, Johann S., dir. ; Selva O'Callaghan, Albert, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Múltiples drogas han sido aprobadas para el tratamiento de cáncer de próstata avanzado en las últimas décadas, incluyendo innovadoras terapias hormonales (abiraterona y enzalutamida), quimioterapias basadas en taxanos (docetaxel y cabazitaxel) y radiofármacos (Rad 223). [...]
Multiple new drugs have been approved for advanced prostate cancer treatment over the last decade including novel endocrine therapies (abiraterone acetate and enzalutamide), taxane-­-based chemotherapies (docetaxel and cabazitaxel) and radiopharmaceuticals (Rad 223). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.